DK170617B1 - Pyrazinoxidforbindelse NF-1616-904, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende denne - Google Patents
Pyrazinoxidforbindelse NF-1616-904, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende denne Download PDFInfo
- Publication number
- DK170617B1 DK170617B1 DK446388A DK446388A DK170617B1 DK 170617 B1 DK170617 B1 DK 170617B1 DK 446388 A DK446388 A DK 446388A DK 446388 A DK446388 A DK 446388A DK 170617 B1 DK170617 B1 DK 170617B1
- Authority
- DK
- Denmark
- Prior art keywords
- oxide compound
- compound
- pyrazine
- pyrazine oxide
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20153787 | 1987-08-11 | ||
JP20153787 | 1987-08-11 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK446388D0 DK446388D0 (da) | 1988-08-10 |
DK446388A DK446388A (da) | 1989-02-12 |
DK170617B1 true DK170617B1 (da) | 1995-11-13 |
Family
ID=16442692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK446388A DK170617B1 (da) | 1987-08-11 | 1988-08-10 | Pyrazinoxidforbindelse NF-1616-904, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende denne |
Country Status (9)
Country | Link |
---|---|
US (1) | US5021419A (es) |
EP (1) | EP0303250B1 (es) |
JP (1) | JPH01131177A (es) |
KR (1) | KR960005150B1 (es) |
CN (1) | CN1028655C (es) |
DE (1) | DE3880231T2 (es) |
DK (1) | DK170617B1 (es) |
ES (1) | ES2054748T3 (es) |
MX (1) | MX9202936A (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69029231T2 (de) | 1989-02-10 | 1997-03-20 | Otsuka Pharma Co Ltd | Indolderivate, ihre herstellung und diese enthaltendes arzneimittel zum verhindern und behandeln von nephritis |
US5238938A (en) * | 1989-02-10 | 1993-08-24 | Otsuka Pharmaceutical Co., Ltd. | Indole derivatives |
CN1038586C (zh) * | 1991-05-01 | 1998-06-03 | 大制药株式会社 | 吡嗪衍生物的制备方法 |
SE529897C2 (sv) | 2006-03-27 | 2007-12-27 | Rottneros Ab | Formpressat tråg |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8427735D0 (en) * | 1984-11-02 | 1984-12-12 | Fujisawa Pharmaceutical Co | Piperazine compound |
-
1988
- 1988-08-10 DE DE88112999T patent/DE3880231T2/de not_active Expired - Fee Related
- 1988-08-10 EP EP88112999A patent/EP0303250B1/en not_active Expired - Lifetime
- 1988-08-10 DK DK446388A patent/DK170617B1/da not_active IP Right Cessation
- 1988-08-10 ES ES88112999T patent/ES2054748T3/es not_active Expired - Lifetime
- 1988-08-10 JP JP63200928A patent/JPH01131177A/ja active Granted
- 1988-08-11 CN CN88104951A patent/CN1028655C/zh not_active Expired - Fee Related
- 1988-08-11 KR KR1019880010242A patent/KR960005150B1/ko not_active IP Right Cessation
-
1990
- 1990-05-07 US US07/518,252 patent/US5021419A/en not_active Expired - Fee Related
-
1992
- 1992-06-17 MX MX9202936A patent/MX9202936A/es unknown
Also Published As
Publication number | Publication date |
---|---|
DE3880231T2 (de) | 1993-10-07 |
DK446388D0 (da) | 1988-08-10 |
CN1032031A (zh) | 1989-03-29 |
ES2054748T3 (es) | 1994-08-16 |
EP0303250A2 (en) | 1989-02-15 |
JPH01131177A (ja) | 1989-05-24 |
KR960005150B1 (ko) | 1996-04-22 |
US5021419A (en) | 1991-06-04 |
EP0303250B1 (en) | 1993-04-14 |
JPH0557273B2 (es) | 1993-08-23 |
KR890003734A (ko) | 1989-04-17 |
DK446388A (da) | 1989-02-12 |
EP0303250A3 (en) | 1990-07-11 |
MX9202936A (es) | 1992-06-30 |
DE3880231D1 (de) | 1993-05-19 |
CN1028655C (zh) | 1995-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07165578A (ja) | 血管再発狭窄症の抑制法 | |
WO1997039999A1 (fr) | Nouveaux composes de terphenyl et medicaments contenant ces composes | |
CN109232684B (zh) | 17-aag葡萄糖苷及其制备方法和在制备抗肿瘤药物中的应用 | |
DK170617B1 (da) | Pyrazinoxidforbindelse NF-1616-904, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende denne | |
KR0135600B1 (ko) | 항암 항생물질 mi43-37f11, 그 제조방법 및 그 용도 | |
JPH06506202A (ja) | 医薬用キサントン誘導体 | |
DK154704B (da) | Fremgangsmaade til fremstilling af et sesquiterpenderivat eller salte deraf | |
SU1074408A3 (ru) | Способ получени 3-0/ @ - @ -глукуронпиранозил/-со сапогенола | |
CN101723997A (zh) | 葛根素糖基化衍生物、其药物组合物、及其制备方法和用途 | |
US4831053A (en) | Composition for prophylaxis and therapy of hepatitis | |
JPH0625069A (ja) | 抗菌、抗ウイルスおよび抗腫瘍抗生物質bu−4641v | |
US6645996B1 (en) | Physiologically active substances | |
US5338758A (en) | Bicyclic diterpene PAF antagonist compounds | |
CN108546247B (zh) | 一种生物碱类化合物在制备抗肥胖药物中用途 | |
RU2221870C2 (ru) | Мумбайстатин, способ его получения и его применение в качестве фармацевтического препарата | |
JP3719689B2 (ja) | 新規物質トリプロスタチン、その製造方法、細胞周期阻害剤および抗腫瘍剤 | |
JP2003503412A (ja) | 海洋放線菌に由来する新規のインドロカルバゾールアルカロイド | |
JP3688446B2 (ja) | 新規テルペン系化合物0406tp−1 | |
JPH01149766A (ja) | インドール誘導体 | |
JP4833461B2 (ja) | 新規血管新生阻害剤 | |
WO2000032604A1 (fr) | Composes de macrolides et methodes d'evaluation d'immunodeprimants | |
JPH07506332A (ja) | 医薬としての複素環化合物のリン酸エステル | |
JPH03290193A (ja) | 生理活性物質tan―1323、その製造法および用途 | |
JPH0987269A (ja) | アセトフタリジン、細胞周期阻害剤および抗腫瘍剤 | |
EP0537199A1 (en) | Compositions for treating hiv-type 1 infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |